Dunkle LM - Search Results

1

Comparative studies of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) with other pyrimidine nucleoside analogues.

Martin JC, Hitchcock MJ, Fridland A, Ghazzouli I, Kaul S, Dunkle LM, Sterzycki RZ, Mansuri MM. Martin JC, et al. Among authors: dunkle lm. Ann N Y Acad Sci. 1990;616:22-8. doi: 10.1111/j.1749-6632.1990.tb17824.x. Ann N Y Acad Sci. 1990. PMID: 1964029 Review. No abstract available.

2

Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection.

Kaul S, Kline MW, Church JA, Dunkle LM. Kaul S, et al. Among authors: dunkle lm. Antimicrob Agents Chemother. 2001 Mar;45(3):758-63. doi: 10.1128/AAC.45.3.758-763.2001. Antimicrob Agents Chemother. 2001. PMID: 11181356 Free PMC article. Clinical Trial.

3

Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex.

Horton CM, Dudley MN, Kaul S, Mayer KH, Squires K, Dunkle L, Anderson R. Horton CM, et al. Antimicrob Agents Chemother. 1995 Oct;39(10):2309-15. doi: 10.1128/AAC.39.10.2309. Antimicrob Agents Chemother. 1995. PMID: 8619587 Free PMC article. Clinical Trial.

4

Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex.

Dudley MN, Graham KK, Kaul S, Geletko S, Dunkle L, Browne M, Mayer K. Dudley MN, et al. J Infect Dis. 1992 Sep;166(3):480-5. doi: 10.1093/infdis/166.3.480. J Infect Dis. 1992. PMID: 1323615 Clinical Trial.

5

A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.

Kline MW, Dunkle LM, Church JA, Goldsmith JC, Harris AT, Federici ME, Schultze ME, Woods L, Loewen DF, Kaul S, et al. Kline MW, et al. Among authors: dunkle lm. Pediatrics. 1995 Aug;96(2 Pt 1):247-52. Pediatrics. 1995. PMID: 7630678 Clinical Trial.

6

The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.

Elion R, Kaul S, Knupp C, Adler M, Cross AP, Dunkle LM, Kelleher T. Elion R, et al. Among authors: dunkle lm. Clin Ther. 1999 Nov;21(11):1853-63. doi: 10.1016/S0149-2918(00)86733-8. Clin Ther. 1999. PMID: 10890257 Clinical Trial.

7

Design and implementation of the stavudine parallel-track program.

Anderson RE, Dunkle LM, Smaldone L, Adler M, Wirtz C, Kriesel D, Cross A, Martin RR. Anderson RE, et al. Among authors: dunkle lm. J Infect Dis. 1995 Mar;171 Suppl 2:S118-22. doi: 10.1093/infdis/171.supplement_2.s118. J Infect Dis. 1995. PMID: 7861016 Clinical Trial.

8

A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults.

Haworth SJ, Christofalo B, Anderson RD, Dunkle LM. Haworth SJ, et al. Among authors: dunkle lm. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):235-8. doi: 10.1097/00042560-199803010-00008. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9495223 Clinical Trial.

9

Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: pharmacokinetic properties, safety, and immunologic and virologic effects.

Kline MW, Fletcher CV, Federici ME, Harris AT, Evans KD, Rutkiewicz VL, Shearer WT, Dunkle LM. Kline MW, et al. Among authors: dunkle lm. Pediatrics. 1996 Jun;97(6 Pt 1):886-90. Pediatrics. 1996. PMID: 8657531 Clinical Trial.

10

Toxic shock syndrome and the acquired immunodeficiency syndrome.

Kline MW, Dunkle LM. Kline MW, et al. Among authors: dunkle lm. Pediatr Infect Dis J. 1988 Oct;7(10):736-8. Pediatr Infect Dis J. 1988. PMID: 3186342 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters